TCR2 Therapeutics Inc. (TCRR)

AI Score

Unlock

1.48

0.00 (0.00%)

At close: May 31, 2023, 8:00 PM

TCR2 Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017
Period Ending	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-41.51M	-61.42M	-31.1M	-31.77M	-29.2M	-27.58M	-26.24M	-24.29M	-21.59M	-18.57M	-17.19M	-16.72M	-16.23M	-13.57M	-14.9M	-12.14M	-10.78M	-8.44M	-7.09M	-6.81M	-4.11M	-4.04M
Interest Income	1.11M	1.01M	510K	298K	117K	38K	38K	n/a	n/a	191K	300K	499K	747K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-40.4M	-60.41M	-30.59M	-31.47M	-29.09M	-27.58M	-26.2M	-24.26M	-21.48M	-18.38M	-16.89M	-16.22M	-15.48M	-12.72M	-13.81M	-11.06M	-9.9M	-7.69M	-6.39M	-6.19M	-3.99M	-4.01M
Net Income	-40.4M	-60.51M	-30.59M	-31.6M	-29.12M	-27.74M	-26.24M	-24.31M	-21.51M	-18.45M	-16.92M	-16.25M	-15.51M	-12.83M	-13.81M	-11.06M	-9.9M	-7.69M	-6.39M	-6.19M	-3.99M	-4.01M
Selling & General & Admin	8.2M	5.8M	6.31M	6M	6.32M	5.21M	5.96M	5.67M	5.67M	4.27M	4.37M	3.81M	4.27M	4.18M	3.52M	3.31M	2.89M	2.22M	1.7M	1.63M	1.22M	1.29M
Research & Development	29.27M	25.74M	24.79M	25.77M	22.88M	22.41M	20.28M	18.63M	15.92M	14.3M	12.82M	12.91M	11.96M	9.39M	11.37M	8.83M	7.89M	6.22M	5.39M	5.17M	2.89M	2.75M
Other Expenses	4.04M	30.42M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	37.47M	31.54M	31.1M	31.77M	29.2M	27.62M	26.24M	24.29M	21.59M	18.57M	17.19M	16.72M	16.23M	13.57M	14.9M	12.14M	10.78M	8.44M	7.09M	6.81M	4.11M	4.04M
Interest Expense	6.97M	n/a	n/a	298K	117K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	37.47M	31.54M	31.1M	31.77M	29.2M	27.62M	26.24M	24.29M	21.59M	18.57M	17.19M	16.72M	16.23M	13.57M	14.9M	12.14M	10.78M	8.44M	7.09M	6.81M	4.11M	4.04M
Income Tax Expense	3K	96K	1K	128K	36K	160K	42K	51K	36K	75K	31K	28K	27K	102K	1.09M	1.08M	872K	751K	702K	622K	127K	25K
Shares Outstanding (Basic)	39.22M	38.81M	38.62M	38.57M	38.51M	38.29M	38.2M	38.18M	37.06M	33.45M	30.34M	24.08M	24.01M	23.96M	23.87M	23.82M	12.33M	23.19M	15.01M	15.01M	15.01M	15.01M
Shares Outstanding (Diluted)	39.22M	38.81M	38.62M	38.57M	38.51M	38.29M	38.2M	38.18M	37.06M	33.45M	30.34M	24.08M	24.01M	23.96M	23.87M	23.82M	12.33M	23.19M	15.01M	15.01M	15.01M	15.01M
EPS (Basic)	-1.03	-1.56	-0.79	-0.82	-0.76	-0.72	-0.69	-0.64	-0.58	-0.55	-0.56	-0.67	-0.65	-0.54	-0.58	-0.46	-0.8	-0.33	-0.43	-0.41	-0.27	-0.27
EPS (Diluted)	-1.03	-1.56	-0.79	-0.82	-0.76	-0.72	-0.69	-0.64	-0.58	-0.55	-0.56	-0.67	-0.65	-0.54	-0.58	-0.46	-0.8	-0.33	-0.43	-0.41	-0.27	-0.27
EBITDA	-32.81M	-1.66M	-30.21M	-31.07M	-28.5M	-26.73M	-25.43M	-23.57M	-20.96M	-17.9M	-16.45M	-15.85M	-15.17M	-12.42M	-13.55M	-10.9M	-9.77M	-7.57M	-6.27M	-6.08M	-3.91M	-3.94M
EBIT	-33.42M	-60.82M	n/a	-31.18M	-28.97M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	8.7M	59.77M	890K	704K	706K	851K	773K	690K	513K	478K	441K	367K	306K	304K	258K	165K	135K	116K	115K	112K	76K	76K